Table 3: The 29 differentially expressed proteins profiles in mouse livers.
Ref. |
Full Name |
Symbol |
Fold |
Disease |
local |
Gene Ontology |
Pathway |
||
3 m |
6 m |
Function |
Process |
||||||
[9] |
Fumarylacetoacetase |
Fah |
0.94 |
2.2 |
Live cancer; hepatic necrosis; implanted secondary tumor |
Nu |
fumarylacetoacetase activity |
L-phenylalanine,tyrosine,phenylalanine, arginine catabolic process; metal ion binding; hydrolase |
Metabolism of amino acids |
[10] |
Ribonuclease UK114 |
Uk114 |
1.3 |
2.1 |
Cancer |
Mito |
endonuclease activity |
inhibition of the translation by cleaving mRNA; endonuclease; tyrosine catabolic process; regulation of translational termination; |
|
[11] |
Betaine-homocysteine S-methyltransferase 1 |
Bhmt |
0.99 |
2 |
Prostate cancer |
Cyto |
homocysteine S-methyltransferase activity |
protein methylation; regulationhomocysteinemetabolicprocess; S-methyltransferase activity; Amino-acid biosynthesis |
Metabolism of amino acids |
[12] |
Isoform 4 of General vesicular transport factor p115 |
Uso1 |
1.1 |
2 |
Liver cancer; Prostate cancer |
Cyto |
protein transporter activity |
intracellular protein transport; apoptosis; actin and microtubules; |
|
[13] |
Sulfite oxidase |
Suox |
1.4 |
1.8 |
Prostate cancer |
Mito |
Sulfite-oxidaseactivity; electron carrier activity |
oxidation-reduction process; response to nutrient |
Metabolism of sulfur |
[14] |
Aspartate aminotransferase |
Got1 |
1.4 |
1.8 |
Liver cancer |
Mito |
L-aspartate:2-oxoglutarate aminotransferaseactivity; phosphatidylserine decarboxylase activity |
amino acid metabolism; the urea and tricarboxylic acid (TCA) cycles |
Metabolism of amino acids |
[15] |
Pterin-4a-carbinolamine dehydratase |
Pcbd1 |
1.3 |
1.8 |
dysplasia; early stages of cancer; malignant transformation; |
Cyto |
phenylalanine 4-monooxygenase activity |
L-phenylalanine catabolic process; positive regulation of transcription; tetrahydrobiopterin biosynthetic process; |
Metabolism of amino acids |
[16] |
Annexin A2 |
Anxa2 |
1.2 |
1.7 |
Liver cancer; |
Cyto |
calcium-dependent phospholipid binding |
cytoskeletal protein binding; Rab-GTPasebinding; phosphatidylinositol-4,5-bisphosphate binding |
Prostaglandin Synthesis and Regulation |
[17] |
4-aminobutyrate aminotransferase |
Abat |
1.2 |
1.7 |
Liver cancer |
Mito |
4-aminobutyrate transaminase activity |
transaminase activity; gamma-aminobutyric acid catabolic; DNA-damaging product formation; |
Metabolism of amino acids |
[18] |
4-hydroxy-2-oxoglutarate aldolase |
Hoga1 |
1.2 |
1.6 |
engineered invasive esophageal squamous cell carcinoma |
Mito |
catalytic activity |
metabolic pathway of hydroxyproline |
Metabolism of hydroxyproline |
[19] |
Serine hydroxymethyl transferase 2 |
Shmt2 |
1.3 |
1.6 |
Prostate cancer |
Mito |
transferase activity |
Regulation of metabolism; Serine+tetrahydrofolate=glycine+5,10-methylene tetrahydrofolate |
Metabolism of cyanoamino acid |
[20] |
Microtubule-associated protein RP/EB family member 1 |
Mapre1 |
1.2 |
1.5 |
Gastric cancer |
Cyto |
microtubule plus-end binding |
Cytoskeleton; mitosis; microtubule organizing center |
Cell Cycle G2/M Transition |
[21] |
Coiled-coil-helix-coiled -coil-helix domain-containing protein 3 |
Chchd3 |
1.4 |
1.5 |
Anaplastic Cancer |
Mito |
phosphatase binding |
mitochondrial fusion |
|
[22] |
Destrin |
Dstn |
1.4 |
1.5 |
Prostate cancer |
Cyto |
actin binding |
actin cytoskeleton; positive regulation of actin filament depolymerization; actin filament severing; |
|
[23] |
Isoform 1 of Phosphotriesterase-related protein |
Pter |
0.95 |
1.5 |
Colon cancer; Leukemia; Prostate cancer |
Cyto |
hydrolase activity; zinc ion binding |
catabolic process |
|
[15] |
Phosphoglycerate kinase 1 |
Pgk1 |
0.97 |
0.67 |
|
Cyto |
Phosphoglycerate kinase activity |
glycolysis; ATP binding; phosphoglycerate kinase activity; transferase activity; |
Gluconeogenesis |
[24] |
Legumain |
Lgmn |
0.93 |
0.66 |
Leukemia; colorectal cancer |
Cyto |
peptidase activity |
serine/threonine kinase activity; cysteine-type endopeptidase; negative regulation of growth |
Lysosome |
[25] |
Isoform 1 of Core histone macro-H2A.1 |
H2afy |
0.99 |
0.64 |
Colon cancer; leukemia |
Nu
|
chromatin binding |
nucleosome assembly; chromatin modification |
Systemic lupus erythematosus |
[26] |
Succinatedehydrogenase [ubiquinone] iron-sulfur subunit, |
Sdhb |
0.98 |
0.61 |
|
Mito |
protein binding |
glycerol-3-phosphate dehydrogenase complex; glycerophosphate shuttle; oxidoreductase |
TCA Cycle |
[27] |
Isoform 1 of Eukaryotic translation initiation factor 4 gamma 1 |
Eif4g1 |
0.84 |
0.59 |
Sorcoma; Leukemia; mitochondrial disorder; Hepatitis; Colorectal cancer |
Cyto |
translation initiation factor activity |
regulation of translation |
Metabolism of mRNA; translation; PI3K Cascade; eIF4F complex; mTOR signalling pathways |
[28] |
Histidinetriad nucleotide-binding protein 2 |
Hint2 |
0.77 |
0.59 |
Prostate cance; Colon caner; leukemia |
Mito |
catalytic activity |
Apoptosis; steroid biosynthetic; hydrolase |
|
[29] |
Cytochrome P450 2F2 |
Cyp2f2 |
0.87 |
0.58 |
Growth supperssion; insulin resistant; |
ER |
Monooxygenase; electron carrier; oxidoreductase activity |
response to toxin; naphthalene metabolic process |
Metabolism of xenobiotics by cytochrome P450 |
[30] |
Cathepsin B |
Ctsb |
0.98 |
0.58 |
mitochondrial disorder; hepatitis; leukemia; prostate cancer |
Mito Cyto |
cysteine-type endopeptidase activity |
response to wounding; endopeptidase; response to stress; negative regulation of apoptosis |
Lysosome |
[31] |
Isoform 1 of Lon protease homolog 2 |
Lonp2 |
0.95 |
0.54 |
Liver cancer; leukemia |
Pero |
protein binding |
signal peptide processing; ATPase; serine-type endopeptidase |
Metabolism of proteins |
[32] |
ATP synthase subunit f |
Atp5j2 |
1 |
0.51 |
hepatitis; leukemia; carcinoma in situ lesion |
Mito |
ATPase activity |
transmembrane transporter; ATPase; mitochondrial proton-transporting ATP synthase complex |
Oxidative phosphorylation; Electron Transport Chain |
[33] |
Majoy urinary protein 20 |
Mup20 |
0.62 |
0.37 |
|
|
pheromone binding |
olfactory learning |
|
[34] |
Isoform 1 of Adenylosuccinate synthetase isozyme 1 |
Adssl1 |
0.89 |
0.63 |
Liver cancer; colorectal cancer; obesity; leukemia |
Cyto
|
adenylosuccinate synthase activity |
purine nucleotide biosynthetic; adenylosuccinate synthase; AMP biosynthetic |
Metabolism of amino acids
|
[35] |
Cytochrome P450 3A13 |
Cyp3a13 |
0.67 |
0.57 |
insulin resistant; liver cancer |
ER |
Monooxygenase; electron carrier; aromatase; iron ion binding |
Metabolism of xenobiotics by cytochrome P451 |
Monooxygenase; electron carrier; aromatase; iron ion binding |
[36] |
Long-chain specific acyl-CoA dehydrogenase |
Acadl
|
1.6 |
1.5 |
sarcoma |
Mito Cyto |
|
lipid catabolic; negative regulation of fatty acid oxidation; long-chain-acyl-CoA dehydrogenase |
TCA Cycle |
Nu: Nuclear; ER: Endoplasmic Reticulum; Cyto: Cytoplasm; Mito: Mitochondrial; Pero: Peroxisome.